Patent · US Active

Polymerizable liquid crystal having a quinoxaline-hydrazone core

US12006463B2 · kind B2 · utility

0Cited by
10References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2020
Grant dateJun 11, 2024
Priority date
Expiry dateNov 17, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC09K2019/0448
  • WIPO fieldBasic materials chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to novel anisotropic compounds of formula (I) as well as liquid crystalline mixtures, films and electro-optical devices comprising the compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.